#ptca catheter

[prathimahospitals]

Centre of Excellence for Cardiac Sciences

𝐒𝐢𝐧𝐠𝐥𝐞 𝐕𝐞𝐬𝐬𝐞𝐥 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 (SVD) 𝐏𝐞𝐫𝐜𝐮𝐭𝐚𝐧𝐞𝐨𝐮𝐬 𝐓𝐫𝐚𝐧𝐬𝐥𝐮𝐦𝐢𝐧𝐚𝐥 𝐂𝐨𝐫𝐨𝐧𝐚𝐫𝐲 𝐀𝐧𝐠𝐢𝐨𝐩𝐥𝐚𝐬𝐭𝐲 (PTCA) 𝐏𝐚𝐜𝐤𝐚𝐠𝐞 @ 𝟏,𝟓𝟗,𝟗𝟗𝟗/-

𝐏𝐚𝐜𝐤𝐚𝐠𝐞 𝐈𝐧𝐜𝐥𝐮𝐝𝐞𝐬: • One Drug-Eluting Stent • One Balloon • One Guide Wire • One Catheter • One Sheath • Investigations - Cath Profile

𝐕𝐚𝐥𝐢𝐝 𝐭𝐢𝐥𝐥: 15th August 2024

[giresearch]

PTCA Balloon Catheter Market Size, Global Industry Trend Analysis and Forecast 2024-2030

Global Info Research announces the release of the report “Global PTCA Balloon Catheter Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030” . This report provides a detailed overview of the market scenario, including a thorough analysis of the market size, sales quantity, average price, revenue, gross margin and market share.The report provides an in-depth analysis of the competitive landscape, manufacturer’s profiles,regional and national market dynamics, and the opportunities and challenge that the market may be exposed to in the near future. Global PTCA Balloon Catheter market research report is a comprehensive analysis of the current market trends, future prospects, and other pivotal factors that drive the market.

PTCA（经皮冠状动脉介入）球囊扩张导管是一种医疗设备，用于治疗冠状动脉疾病，特别是冠状动脉狭窄。该导管通过在病人的动脉中引入一个膨胀的球囊来扩张狭窄的动脉段。PTCA球囊扩张导管通过导管的内部将球囊引导到狭窄的位置，然后通过充气球囊来扩张动脉壁，从而恢复动脉的通畅性。这种介入治疗可以帮助改善心脏供血，减轻心绞痛症状，甚至可能避免心肌梗塞等严重并发症。 According to our (Global Info Research) latest study, the global PTCA Balloon Catheter market size was valued at US$ 1132 million in 2023 and is forecast to a readjusted size of USD 1711 million by 2030 with a CAGR of 5.5% during review period. Global key players of PTCA Balloon Catheter include Boston Scientific, Abbott, Medtronic, Asahi Intecc, Terumo, etc. The top five players hold a share about 76%. Asia-Pacific is the largest market, and has a share about 41%, followed by America and Europe with share 30% and 25%, separately. In terms of product type, Semi-Compliant is the largest segment, occupied for a share of 54%. In terms of application, Hospital has a share about 85 percent. This report is a detailed and comprehensive analysis for global PTCA Balloon Catheter market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Market Segmentation PTCA Balloon Catheter market is split by Type and by Application. For the period 2019-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type: Semi-Compliant、Non Compliant

Market segment by Application:Hospital、Clinic

Major players covered: Boston Scientific、Abbott、Medtronic、Asahi Intecc、Terumo、BrosMed Medical、MicroPort、Bluesail、Lepu Medical、Philips、Translumina、Sinomed、Teleflex、Yinyi、Demax

The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe PTCA Balloon Catheter product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top manufacturers of PTCA Balloon Catheter, with price, sales, revenue and global market share of PTCA Balloon Catheter from 2019 to 2024. Chapter 3, the PTCA Balloon Catheter competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the PTCA Balloon Catheter breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030. Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030. Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and PTCA Balloon Catheter market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030. Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis. Chapter 13, the key raw materials and key suppliers, and industry chain of PTCA Balloon Catheter. Chapter 14 and 15, to describe PTCA Balloon Catheter sales channel, distributors, customers, research findings and conclusion.

Our Market Research Advantages： Global Perspective: Our research team has a strong understanding of the  company in the global PTCA Balloon Catheter market.Which offers pragmatic data to the company. Aim And Strategy: Accelerate your business integration, provide professional market strategic plans, and promote the rapid development of enterprises. Innovative Analytics: We have the most comprehensive database of resources , provide the largest market segments and business information.

About Us: Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provide market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.

[advinhealthcare]

Arab Health 2024 - Advin Cardiology Products

Experience our supreme quality cardiology products range includes Inflation Device, PTCA Balloon Catheter, PTCA Y Connector Kit, Embolectomy Catheter at ArabHealth 2024.

We are excitedly awaiting your participation!

📅 Date: January 29 - February 1, 2024

📍 Stand No.: OS.B85

🏰 Venue: Dubai World Trade Center, UAE

Email: exports@advinhealthcare.com

Website: https://advinhealthcare.com

#arabHealth #arabhealth2024 #arabhealthexhibition #medicalexhibition #arabhealthdubai #medicalproducts #advinhealthcare #advinurology #cardiologia

[neha24blog]

Interventional Cardiology Devices Market Trends Analysis Report By Product, Region And Forecast To 2028: Grand View Research Inc.

San Francisco, 12 Dec 2023: The Report Interventional Cardiology Devices Market Size, Share & Trends Analysis Report By Product (Coronary Stents, PTCA Balloon Catheters, Accessory Devices), By Region, And Segment Forecasts, 2023 – 2030 The global interventional cardiology devices market size is expected to reach USD 22.35 billion by 2030, according to a new report by Grand View Research Inc. The…

[delvenservices]

Percutaneous Coronary Intervention Market Report Scope & Insights

Percutaneous Coronary Intervention Market Size to Reach at a Highest CAGR of 7.2% by 2028

Percutaneous Coronary Intervention Market, By Type (Balloon Angioplasty, Angioplasty With Stent, Laser Angioplasty, Rotational Atherectomy, CTO (Chronic Total Occlusions), Coronary Guidewires, Coronary Stents, Ptca Catheters, Embolic Protection Devices (EPDs)), Techniques (Advanced Imaging, Fractional Flow Reserve (FRR), Radial Artery Access), Disease (Angina, Myocardial Infraction (MI), Multivessel Coronary Artery Disease (CAD)), End User (Hospital, Cardiac Centers, Ambulatory Surgical Centers, Specialty Centers, Cath Labs, Others), Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Market Overview

The global percutaneous coronary intervention market is anticipated to reach USD 16.7 billion by 2020 growing at a CAGR of 7.2% during the forecasting period, 2020-2028. Percutaneous Coronary Intervention is a non-invasive procedure that is used for treating the narrowing arteries of the heart in coronary artery diseases including angina, acute myocardial infarction, and multivessel coronary artery disease (CAD). Factors such as rising risk factors associated with heart diseases such as obesity, smoking, and substance abuse, fatty foods, etc and rising geriatric and pediatric population are some of the major drivers for the market of percutaneous coronary intervention.

Get a Sample Copy of the Report: https://www.delvens.com/get-free-sample/percutaneous-coronary-intervention-market-trends-forecast-till-2028

Key Findings

The global percutaneous coronary intervention market is segmented into type, technique, disease, end-user, and geography.

The type segment is segmented into Balloon Angioplasty, Angioplasty with Stent, Laser Angioplasty, Rotational Atherectomy, CTO (Chronic Total Occlusions), Coronary Guidewires, Coronary Stents, PTCA Catheters, Embolic Protection Devices (EPDs). Balloon Angioplasty segment is further segmented into Aorta, Iliac Artery, Femoral Artery, Popliteal Artery, Tibial and Peroneal Arteries. Angioplasty with Stent is further segmented into Dual Therapy Stent, Bioresorbable Vascular Scaffold, Bio-Engineered Stent, Drug-Eluting Stent, and bare-metal stent. The Rotational Atherectomy segment is further segmented into Low-Speed Rotational Atherectomy, High-Speed Rotational Atherectomy. CTO (Chronic Total Occlusions) segment is further segmented into Retrograde Technique, Anterograde Technique with Wire Scaling, Anterograde Dissection, and Reentry Technique and Others.

Techniques are segmented into Advanced Imaging, Fractional Flow Reserve (FRR), and Radial Artery Access

The disease is segmented into Angina, Myocardial Infraction (MI), Multivessel Coronary Artery Disease (CAD). Angina is further segmented into Unstable Angina, Stable Angina. Myocardial Infraction is further segmented into Acute Non-ST Elevation Myocardial Infarction, Acute ST-Elevation Myocardial Infarction. Multivessel Coronary Artery Disease is further segmented into Obstructive Coronary Artery Disease and Spontaneous Coronary Artery Dissection (SCAD).

End-User is segmented into Hospital, Cardiac Centers, Ambulatory Surgical Centers, Specialty Centers, Cath Labs, and Others

Geographically, the global percutaneous coronary intervention market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions.

Make an Inquiry Before Buying: https://www.delvens.com/Inquire-before-buying/percutaneous-coronary-intervention-market-trends-forecast-till-2028

Regional Analysis

North America region is the largest contributor to the percutaneous coronary intervention market in the forecast period 2020-2028.

Competitive Landscape

Key players in global percutaneous coronary intervention market

Abbott,

Asahi Intecc Company Limited,

B. Braun Melsungen AG,

Biosensors International Group, Ltd.,

Biotronik,,

Boston Scientific Corporation,

C. R. Bard, Inc.,

Comed B.V.,

Cook,

Cordis,

Medtronic,

Merit Medical System,

Terumo Corporation,

Philips Healthcare

Recent Developments

The companies have come up with various promotional activities in from of launch, investment, acquisition, and other, for instance:

In 2019, Abbott has announced to acquire Cephea Valve Technologies Inc., which is engaged in developing a minimally invasive mitral valve replacement system. 

In 2018, Medtronic has announced the launch of the first 2.0 mm Drug-Eluting Stent in the United States designed to treat patients with small vessels

Purchase the Report at: https://www.delvens.com/checkout/percutaneous-coronary-intervention-market-trends-forecast-till-2028

Reasons to Acquire

Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors

Gain authentic and granular data access for the percutaneous coronary intervention market so as to understand the trends and the factors involved behind changing market situations

Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future

In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Browse More Reports:

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

Contact Us:

UNIT NO. 2126, TOWER B,

21ST FLOOR ALPHATHUM

SECTOR 90 NOIDA 201305, IN

+44-20-8638-5055

SALES@DELVENS.COM

[nitasonwane]

Interventional Cardiology Devices Market Size, Share, Growth and Demand

Interventional Cardiology Devices Market Size, Share & COVID-19 Impact Analysis, By Type (Coronary Vascular Devices and Structural Heart Devices), By Product (Coronary Stents, Heart Valve Therapy Devices, Angioplasty Balloons, Atherectomy Devices, Intravascular Ultrasound (IVUS) Devices, and Others), By End User (Hospitals & Ambulatory Surgical Centers and Clinics & Others), and Regional Forecasts, 2022-2029

The global interventional cardiology devices market size was valued at USD 13.67 billion in 2021. The market is projected to grow from USD 14.61 billion in 2022 to USD 23.61 billion by 2029, exhibiting a CAGR of 7.1% during the forecast period. Prevalence of Cardiovascular Diseases (CVDs) such as coronary heart disease, stroke, and atrial fibrillation to propel the market progression. There is focus on the production and launch of advanced devices to meet the growing demand for minimally invasive devices. Fortune Business Insights™ shares this information in its report titled “Interventional Cardiology Devices Market, 2022-2029.”

COVID-19 Impact:

Reduction in Number of Elective Surgeries Impeded Market Growth

The COVID-19 pandemic negatively affected the market in 2020 due to elective surgical procedures across the globe, significantly affecting the global market. According to PLOS, in September 2022, in Michigan, the total PCI procedural volume from March to December 2020 declined by 15.2% compared to 2019. In 2021, all elective and interventional surgeries were conducted in several countries across the globe. Preference for interventional procedures due to non-invasive and infection control among patients is set to propel the market growth.

Report Coverage

The report provides a detailed analysis of the top segments and the latest trends in the market. It comprehensively discusses the driving and restraining factors and the impact of COVID-19 on the market. Additionally, it examines the regional developments and the strategies undertaken by the market's key players.

Drivers and Restraints

Rising Number of Product Launches by Key Players to Fuel Market Progression

Rising number of product launches by the key players is anticipated to drive the interventional cardiology devices market growth. Developing nations such as China, India, and Brazil have a high number of cardiovascular diseases such as valvar defects and atrial stenosis, which lead to a high demand for interventional cardiology devices for treatment. Partnerships among major players to conduct several clinical trials on interventional devices are increasing. In March 2021, B. Braun SE partnered with Infraredx for the implementation of an Investigational Device Exemption (IDE) clinical trial for the SeQuent Please ReX drug-coated PTCA balloon catheter.

List of Key Players Profiled in the Report

·         Edward Lifesciences (U.S.)

·         Boston Scientific Corporation (U.S.)

·         Abbott (U.S.)

·         Medtronic (Ireland)

·         BIOTRONIK SE & Co. KG (Germany)

·         iVascular (Spain)

·         Terumo Corporation (Japan)

·         Teleflex Incorporated (U.S.)

·         B. Braun SE (Germany)

·         Alvimedica (Turkey)

[dtcatheters]

The artificial fluoropolymer known as PTFE, or polytetrafluoroethylene, has a variety of uses. After being identified in late 1930, and since then, it has been synonymous with synthetic polymers and the most frequently used substance in analytic and medicinal fields.

[prathimahospitals]

Centre of Excellence for Cardiac Sciences

𝐓𝐰𝐨 𝐕𝐞𝐬𝐬𝐞𝐥 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 (2VD) 𝐏𝐞𝐫𝐜𝐮𝐭𝐚𝐧𝐞𝐨𝐮𝐬 𝐓𝐫𝐚𝐧𝐬𝐥𝐮𝐦𝐢𝐧𝐚𝐥 𝐂𝐨𝐫𝐨𝐧𝐚𝐫𝐲 𝐀𝐧𝐠𝐢𝐨𝐩𝐥𝐚𝐬𝐭𝐲 (PTCA) 𝐏𝐚𝐜𝐤𝐚𝐠𝐞 @ 𝟐,𝟏𝟒,𝟗𝟗𝟗/-

𝐏𝐚𝐜𝐤𝐚𝐠𝐞 𝐈𝐧𝐜𝐥𝐮𝐝𝐞𝐬: • Two Drug-Eluting Stent • One Balloon • One Guide Wire • One Catheter • One Sheath • Investigations - Cath Profile

𝐕𝐚𝐥𝐢𝐝 𝐭𝐢𝐥𝐥: 15th August 2024

[myvitelecom]

Discover the Details on Mozec NC - A PTCA Balloon Catheter Created by Meril Life

Explore details about Mozec NC, a PTCA Balloon Catheter which has a Low 0.019” distal tip entry profile enabling flexiblity after stent placement.. Download the Meril Life brochure to learn more about Mozec NC.

https://www.merillife.com/medical-devices/vascular-intervention/coronary/balloon-catheters/ptca/mozec-nc-ptca-bdc

[jean-perry]

https://www.marketwatch.com/press-release/global-percutaneous-transluminal-coronary-angioplasty-ptca-balloon-catheters-market-business-outlook-2023-new-upcoming-trends-growing-cagr-and-demand-types-applications-revenue-forecast-2030-by-2757254.html

[advinhealthcare]

Advin Health Care - PTCA Balloon Catheter

Email: exports@advinurology.com

Website: https://advinhealthcare.com

#advinhealthcare #advinurology #ptcaballooncatheter #ptcaballoon #medicaldevices #angiography #angiogrphy #cardio #cardiology #cardiologist #cardiologyhospital #cardiologist #cardiologyinstruments #cardiovascular #cardio #cardiologyequipment #cardiologo